Surrozen focuses on ophthalmology programs, raising $175 million to advance treatments while discontinuing SZN-043 for alcohol-associated hepatitis. Surrozen, Inc. has announced a strategic shift to ...
GREENVILLE, N.C. (WNCT) — ECU Health welcomed its first class of ophthalmology residents on June 25, marking another significant milestone in the growth of its Graduate Medical Education programs ...
EMERYVILLE, Calif., Aug. 05, 2024 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading clinical-stage genetic medicines company focused on unlocking the full ...